RxDoctor Payments Data

James Walker, MD

Critical Care Medicine · Wichita, KSNPI 1871640946

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AstraZeneca at 36.6% of the total. Reporting peaked in 2024 at $394 and has fallen 95.5% since, to $18 in 2025.

$637in general payments, 2019–2025

Across 8 payments — averaging $79.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$233
  • Imperative Care, Inc$120
  • Genentech USA, Inc.$83
  • Haemonetics Corporation$79
  • Edwards Lifesciences$62
  • Microtransponder, Inc.$41
  • plus $18 from 1 others
$154,609in research payments, 2019–2025

Across 62 payments — averaging $2493.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$155K

What the payments were for

  • Food & beverage$637100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$637 in reported general payments places this provider in the 70th percentile of 35 critical care medicine providers in Kansas.

See all critical care medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$62,121
Medicare patients
179
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →